Dr Kathrin Lauber
Job Title
Research Fellow
Photo
Email
kathrin.lauber@ed.ac.uk
Personal website
ORCiD
Twitter username
https://twitter.com/kathrin_lauber/
Building (Address)
22 George SquareCity (Address)
EdinburghResearch interests
Research themes
Research interests
My research focuses on the intersection of corporate power, governance, and meta-regulation in the context of health and climate policy. I am particularly interested in food policy, and my current work concentrates on the global level of governance and the European Union.
Works within
Publications by user content
| Publication | Research Explorer link |
|---|---|
|
Brooks E, Lauber K. Administering a chill pill? Better regulation and the potential for regulatory chill in European Union health policy. Journal of Health Politics, Policy and Law. 2024 Oct 1;49(5):743-768. 11257072. Epub 2024 Sept 4. doi: 10.1215/03616878-11257072 |
View |
|
Brooks E, Lauber K, Greer SL. Health policy lobbying in the European Union. In Coen D, Katsaitis A, editors, Handbook on Lobbying and Public Policy. Edward Elgar Publishing. 2024. p. 395-407. (Handbooks of Research on Public Policy series). Epub 2024 Jul 9. doi: 10.4337/9781800884717.00041 |
View |
|
Springett D, Lauber K, Gillison F, Wort G, Augustine D, Thompson D et al. The acceptability of technology-enabled physical activity feedback in cardiac patients and health care professionals. Health and Technology. 2024 Jun 20. Epub 2024 Jun 20. doi: 10.1007/s12553-024-00888-x |
View |
|
Lauber K, Brooks E. A missed opportunity for public health: How impact assessment shaped EU rules on the marketing of unhealthy commodities to children. SSM - Qualitative Research in Health. 2024 Jun;5:1-25. 100369. Epub 2023 Nov 24. doi: 10.1016/j.ssmqr.2023.100369 |
View |
|
Lauber K, Brooks E. Why meta-regulation matters for public health: The case of the EU better regulation agenda. Globalization and Health. 2023 Dec;19(1):70. Epub 2023 Sept 14. doi: 10.1186/s12992-023-00971-4 |
View |
|
Maani N, Lauber K. Tall Tales and Hidden Shallows: The Single-Minded Influence of the Alcohol Industry Over Public Discourse, Science, and Government Bodies—A Comment on Mitchell and McCambridge (2023). Journal of Studies on Alcohol and Drugs. 2023 May 3;84(2):335-336. doi: 10.15288/jsad.23-00070 |
View |
|
Hawkins B, Brooks E, Ralston R, Lauber K, Karreman N, Steele S. The law of diminishing returns? The challenge of using freedom of information legislation for health policy research. Critical Public Health. 2023;33(4):383-386. Epub 2023 Jul 28. doi: 10.1080/09581596.2023.2220134 |
View |
|
Lauber K. Framing marketing responses to national regulation: The four Ps in transnational corporate political discourse; Comment on “Understanding Marketing Responses to a Tax on Sugary Drinks: A Qualitative Interview Study in the United Kingdom, 2019”. International Journal of Health Policy and Management. 2023;12(1):1-4. Epub 2022 Nov 20. |
View |
|
Ulucanlar S, Lauber K, Fabbri A, Hawkins B, Mialon M, Hancock L et al. Corporate political activity: Taxonomies and model of corporate influence on public policy. International Journal of Health Policy and Management. 2023;12(1):1-22. 7292. Epub 2023 Jun 6. doi: 10.34172/ijhpm.2023.7292 |
View |
|
Lauber K, Rippin H, Wickramasinghe K, Gilmore AB. Corporate political activity in the context of sugar-sweetened beverage tax policy in the WHO European Region. European Journal of Public Health. 2022 Oct;32(5):786-793. Epub 2022 Sept 13. doi: 10.1093/eurpub/ckac117 |
View |
|
Carriedo A, Lauber K, Miller MM, Ralston R. Lacking clarity or strategic ambiguity? Comment on "Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-Communicable Diseases". International Journal of Health Policy and Management. 2022 Jul 11;11(7):1215–1218 . Epub 2021 Sept 1. doi: 10.34172/ijhpm.2021.113 |
View |
|
Lauber K, Hunt D, Gilmore AB, Rutter H. Corporate political activity in the context of unhealthy food advertising restrictions across Transport for London: A qualitative case study . PLoS Medicine. 2021 Sept 2. doi: 10.1371/journal.pmed.1003695 |
View |
|
Lauber K, McGee D, Gilmore AB. Commercial use of evidence in public health policy: A critical assessment of food industry submissions to global-level consultations on non-communicable disease prevention. BMJ Global Health. 2021 Aug 23;6(8). doi: 10.1136/bmjgh-2021-006176 |
View |
|
Lauber K, Rutter H, Gilmore AB. Big food and the World Health Organization: A qualitative study of industry attempts to influence global-level non-communicable disease policy. BMJ Global Health. 2021 Jun 11;6(6). doi: 10.1136/bmjgh-2021-005216 |
View |
|
Evans-Reeves K, Lauber K, Hiscock R. The 'filter fraud' persists: The tobacco industry is still using filters to suggest lower health risks while destroying the environment. Tobacco Control. 2021 Apr 26. doi: 10.1136/tobaccocontrol-2020-056245 |
View |
|
Matthes BK, Lauber K, Zatoński M, Robertson L, Gilmore AB. Developing more detailed taxonomies of tobacco industry political activity in low-income and middle-income countries: Qualitative evidence from eight countries. BMJ Global Health. 2021 Mar 23;6(3). doi: 10.1136/bmjgh-2020-004096 |
View |
|
Lauber K, Ralston R, Mialon M, Carriedo A, Gilmore AB. Non-communicable disease governance in the era of the sustainable development goals: A qualitative analysis of food industry framing in WHO consultations. Globalization and Health. 2020 Aug 26;16:76. doi: 10.1186/s12992-020-00611-1 |
View |
|
Evans-Reeves KA, Hiscock R, Lauber K, Gilmore AB. Prospective longitudinal study of tobacco company adaptation to standardised packaging in the UK: Identifying circumventions and closing loopholes. BMJ Open. 2019 Sept 24;9(9):e028506. doi: 10.1136/bmjopen-2018-028506 |
View |